Project Supervisor

María Berdasco


In the last years, we are witnessing tremendous progress related to the scientific knowledge on epigenetic contribution and its development towards translational research leading to implementation in the clinic. Our group is focused on elucidating which epigenetic alterations are druggable targets in a tumor, and the means for their therapeutic exploitation in the framework of Precision Medicine.

See more

To this end, we aim at answering three key questions that would turn this hypothesis into a clinical reality: (1) Which epigenetic alterations are “druggable” targets for cancer management; (2) How can we efficiently treat cancers that depend on epigenetic alterations; and (3) Who would benefit of such epigenetic-based therapeutic strategy?

See less